MedUni Vienna: Prostate cancer: Protein identified to reduce tumour growth

As prostate cancer progresses, it becomes increasingly aggressive and can metastasise. In this form, the tumour is…

Uni Vienna: Uptake of tire wear additives by vegetables grown for human consumption

Irrigation with treated wastewater and sewage sludge brings tire additives into the leafy vegetables

Übernahme im Tiefkühlbereich: concept cool baut eigenes Markenportfolio weiter aus und übernimmt in einem Asset Deal das Food-Startup Rebel Meat.

Der österreichische Spezialist für Food-Solutions im Tiefkühlbereich, die in St. Pölten ansässige concept cool…

Hookipa Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting

- Encouraging clinical activity with observed deepening of responses in 35 evaluable first line head and neck patients…

Quantro Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments

QUANTRO Therapeutics (QUANTRO), a pioneer in the discovery of first-in-class transcription factor targeting cancer…

MedUni Vienna: Heart: New heart valve prosthesis enables broader applicability

A catheter-based tricuspid valve replacement with a newly approved heart valve was performed for the first time in…

LISAvienna News

LISAvienna: wings4innovation advances the search for a new therapeutic approach to the treatment of osteoarthritis

Osteoarthritis is a painful, chronic joint disease. Supported by wings4innovation, the KHAN-I Fund is providing…

Lepton and TAmiRNA collaborate on microRNA immune therapy discovery

Lepton Pharmaceuticals LTD (Lepton), a biopharmaceutical company, focused on discovery and development of novel…

enGenes technologies deliver cost-effective, high-yield bioprocesses over broad range of for specific Applications

enGenes Biotech has developed a suite of patented technology platforms for the customized production of recombinant…

Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the results of two…

Europlasma: LFB übernimmt Amber Plasma in der Tschechischen Republik und erweitert sein Netzwerk zur Plasmagewinnung in Europa.

Paris - 30. Mai 2024 - LFB gibt die Übernahme von Amber Plasma durch sein Tochterunternehmen Europlasma bekannt.

Vetmeduni Wien: Petra Winter ist neue EAEVE-Präsidentin

Die Rektorin der Vetmeduni in Wien leitet seit 30. Mai 2024 eine der wichtigsten veterinärmedizinischen Vereinigungen…